VERAMYST (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the VERAMYST drug offered from GlaxoSmithKline LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | fluticasone furoate |
| SUBSTANCE NAME: | FLUTICASONE FUROATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | NASAL |
| DOSAGE FORM: | SPRAY, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-05-15 |
| END MARKETING DATE: | 2019-07-31 |
VERAMYST HUMAN PRESCRIPTION DRUG Details:
| Item Description | VERAMYST from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 27.5(ug/1) |
| START MARKETING DATE: | 2007-05-15 |
| END MARKETING DATE: | 2019-07-31 |
| PRODUCT ID: | 0173-0753_1ddb118d-95f4-4e03-b7f1-403e1ad6e82a |
| PRODUCT NDC: | 0173-0753 |
| APPLICATION NUMBER: | NDA022051 |
Other FLUTICASONE FUROATE Pharmaceutical Manufacturers / Labelers:
